BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Isaacs KL. How prevalent are extraintestinal manifestations at the initial diagnosis of IBD? Inflamm Bowel Dis. 2008;14 Suppl 2:S198-S199. [PMID: 18816779 DOI: 10.1002/ibd.20597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2011;7:235-241. [PMID: 21857821 DOI: 10.1007/978-3-319-26811-8_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Hagen JW, Swoger JM, Grandinetti LM. Cutaneous manifestations of crohn disease. Dermatol Clin. 2015;33:417-431. [PMID: 26143422 DOI: 10.1016/j.det.2015.03.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 6.2] [Reference Citation Analysis]
3 Ott C, Takses A, Obermeier F, Schnoy E, Müller M. Smoking increases the risk of extraintestinal manifestations in Crohn's disease. World J Gastroenterol 2014; 20(34): 12269-12276 [PMID: 25232261 DOI: 10.3748/wjg.v20.i34.12269] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
4 Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D, Paoluzi P, Vernia P. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol 2014; 20(46): 17463-17467 [PMID: 25516659 DOI: 10.3748/wjg.v20.i46.17463] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
5 Singh B, Kedia S, Konijeti G, Mouli VP, Dhingra R, Kurrey L, Srivastava S, Pradhan R, Makharia G, Ahuja V. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype. Indian J Gastroenterol. 2015;34:43-50. [PMID: 25663290 DOI: 10.1007/s12664-015-0538-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
6 Karmiris K, Avgerinos A, Tavernaraki A, Zeglinas C, Karatzas P, Koukouratos T, Oikonomou KA, Kostas A, Zampeli E, Papadopoulos V. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease. J Crohns Colitis. 2016;10:429-436. [PMID: 26721936 DOI: 10.1093/ecco-jcc/jjv232] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 7.9] [Reference Citation Analysis]
7 van Linschoten RCA, van Leeuwen N, Nieboer D, Birnie E, Scherpenzeel M, Verweij KE, de Jonge V, Hazelzet JA, van der Woude CJ, West RL, van Noord D; Southwest Netherlands IBD Study Group. Value-based care pathway for inflammatory bowel disease: a protocol for the multicentre longitudinal non-randomised parallel cluster IBD Value study with baseline period. BMJ Open 2022;12:e050539. [PMID: 35022169 DOI: 10.1136/bmjopen-2021-050539] [Reference Citation Analysis]
8 Bilski J, Mazur-Bialy A, Brzozowski B, Magierowski M, Zahradnik-Bilska J, Wójcik D, Magierowska K, Kwiecien S, Mach T, Brzozowski T. Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence. Pharmacol Rep 2016;68:827-36. [PMID: 27255494 DOI: 10.1016/j.pharep.2016.04.009] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]